We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SVT:LSESevern Trent Plc Analysis

Data as of 2026-03-14 - not real-time

£3,158.00

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Severn Trent trades at £31.58, just above its 20‑day SMA (£31.73) and comfortably above the 50‑day SMA (£30.17), confirming a short‑term bullish price bias. However, the MACD histogram remains negative (‑£0.18) and the RSI sits at a neutral 55, signalling limited upside momentum. The company delivers a solid 18% revenue growth and a strong 3.91% dividend yield, but the payout ratio exceeds 100% (116%) and free cash flow is negative, raising questions about dividend sustainability. The latest fair‑value revision to £30.20 places the current price roughly 2–3% above the adjusted intrinsic estimate, suggesting the stock is at best fairly valued.
Regulatory exposure is moderate; the water sector’s stable, regulated cash‑flows underpin the business, yet the high debt‑to‑equity (≈597) and modest beta (0.06) highlight low market volatility but elevated financial leverage. With stable trading volumes and a low‑beta profile, the stock presents limited liquidity risk, while the UK‑centric operations keep geographic and currency risk low.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near 20‑day SMA with bullish trend but MACD bearish
  • Neutral RSI indicating limited short‑term momentum
  • Support level at £30.39 providing downside cushion

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong 18% revenue growth and attractive dividend yield
  • Fair‑value estimate (£30.20) slightly below current price
  • Regulated utility model delivering stable cash‑flows

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Long‑term regulated water demand and renewable‑energy assets
  • High leverage (debt‑to‑equity ~597) and unsustainable payout ratio
  • Low beta and low volatility supporting defensive profile

Key Metrics & Analysis

Financial Health

Revenue Growth18.00%
Profit Margin11.92%
P/E Ratio30.1
ROE17.41%
ROA2.91%
Debt/Equity596.74
P/B Ratio526.6
Op. Cash Flow£1.0B
Free Cash Flow£-970550016
Industry P/E23.3

Technical Analysis

TrendBullish
RSI55.0
Support£3,039.00
Resistance£3,298.00
MA 20£3,173.40
MA 50£3,016.74
MA 200£2,766.54
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair Value£3,625.24
Target Price£3,075.62
Upside/Downside-2.61%
GradeFair
TypeBlend
Dividend Yield3.91%

Risk Assessment

Beta0.06
Volatility22.68%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.